Hims & Hers Gains, Abbott Slides, Allbirds Sinks
On this episode of Stock Movers:- Hims & Hers shares are extending their advance for a second straight session, gaining as much as 8.4% on Thursday. The telehealth firm’s stock rallied 14% on Wednesday, after HHS Secretary Robert F. Kennedy Jr. said the FDA is seeking to remove 12 peptides from Category 2 restrictions-Abbott (ABT) shares slide as much as 5.1% to the lowest intraday level since 2023 after the medical-devices firm cut its adjusted earnings per share guidance for the full year due to the impact of its acquisition of Exact Sciences. Abbott also gave profit guidance for the…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.